Nucana presents promising data on nuc-7738 at the european society of medical oncology (esmo) annual meeting 2022

Nuc-7738 demonstrates encouraging anti-tumor activity and a favorable safety profile across a variety of solid tumors
NCNA Ratings Summary
NCNA Quant Ranking